ID TRPC5_HUMAN Reviewed; 973 AA. AC Q9UL62; B2RP53; O75233; Q5JXY8; Q9Y514; DT 01-DEC-2000, integrated into UniProtKB/Swiss-Prot. DT 01-MAY-2000, sequence version 1. DT 11-MAY-2016, entry version 143. DE RecName: Full=Short transient receptor potential channel 5; DE Short=TrpC5; DE AltName: Full=Transient receptor protein 5; DE Short=TRP-5; DE Short=hTRP-5; DE Short=hTRP5; GN Name=TRPC5; Synonyms=TRP5; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Fetal brain; RX PubMed=10493832; DOI=10.1006/geno.1999.5924; RA Sossey-Alaoui K., Lyon J.A., Jones L., Abidi F.E., Hartung A.J., RA Hane B., Schwartz C.E., Stevenson R.E., Srivastava A.K.; RT "Molecular cloning and characterization of TRPC5 (HTRP5), the human RT homologue of a mouse brain receptor-activated capacitative Ca(2+) RT entry channel."; RL Genomics 60:330-340(1999). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15772651; DOI=10.1038/nature03440; RA Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D., RA Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., RA Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., RA Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S., RA Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R., RA Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L., RA Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A., RA Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S., RA Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R., RA Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M., RA Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N., RA Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D., RA Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W., RA Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C., RA Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C., RA Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S., RA Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S., RA Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., RA Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., RA Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., RA Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L., RA Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P., RA Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S., RA Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A., RA Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J., RA Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J., RA Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S., RA de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z., RA Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C., RA Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W., RA Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D., RA Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H., RA McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., RA Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., RA Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., RA Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J., RA Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E., RA Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S., RA Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K., RA Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D., RA Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R., RA Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., RA Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., RA Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L., RA Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A., RA Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L., RA Williams G., Williams L., Williamson A., Williamson H., Wilming L., RA Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H., RA Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A., RA Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F., RA Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., RA Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., RA Gibbs R.A., Beck S., Rogers J., Bentley D.R.; RT "The DNA sequence of the human X chromosome."; RL Nature 434:325-337(2005). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., RA Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., RA Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., RA Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R., RA Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H., RA Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G., RA Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W., RA Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA RT project: the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP TISSUE SPECIFICITY. RX PubMed=9687496; DOI=10.1093/emboj/17.15.4274; RA Philipp S., Hambrecht J., Braslavski L., Schroth G., Freichel M., RA Murakami M., Cavalie A., Flockerzi V.; RT "A novel capacitative calcium entry channel expressed in excitable RT cells."; RL EMBO J. 17:4274-4282(1998). RN [6] RP SUBUNIT. RX PubMed=12032305; DOI=10.1073/pnas.102596199; RA Hofmann T., Schaefer M., Schultz G., Gudermann T.; RT "Subunit composition of mammalian transient receptor potential RT channels in living cells."; RL Proc. Natl. Acad. Sci. U.S.A. 99:7461-7466(2002). RN [7] RP INTERACTION WITH MX1. RX PubMed=15757897; DOI=10.1074/jbc.M500391200; RA Lussier M.P., Cayouette S., Lepage P.K., Bernier C.L., Francoeur N., RA St-Hilaire M., Pinard M., Boulay G.; RT "MxA, a member of the dynamin superfamily, interacts with the ankyrin- RT like repeat domain of TRPC."; RL J. Biol. Chem. 280:19393-19400(2005). RN [8] RP INTERACTION WITH CABP1. RX PubMed=15895247; DOI=10.1007/s00424-005-1419-1; RA Kinoshita-Kawada M., Tang J., Xiao R., Kaneko S., Foskett J.K., RA Zhu M.X.; RT "Inhibition of TRPC5 channels by Ca2+-binding protein 1 in Xenopus RT oocytes."; RL Pflugers Arch. 450:345-354(2005). RN [9] RP FUNCTION AS CALCIUM CHANNEL, ENZYME REGULATION, AND SUBCELLULAR RP LOCATION. RX PubMed=16284075; DOI=10.1113/jphysiol.2005.097998; RA Shimizu S., Yoshida T., Wakamori M., Ishii M., Okada T., Takahashi M., RA Seto M., Sakurada K., Kiuchi Y., Mori Y.; RT "Ca2+-calmodulin-dependent myosin light chain kinase is essential for RT activation of TRPC5 channels expressed in HEK293 cells."; RL J. Physiol. (Lond.) 570:219-235(2006). RN [10] RP INTERACTION WITH RNF24. RX PubMed=17850865; DOI=10.1016/j.ceca.2007.07.009; RA Lussier M.P., Lepage P.K., Bousquet S.M., Boulay G.; RT "RNF24, a new TRPC interacting protein, causes the intracellular RT retention of TRPC."; RL Cell Calcium 43:432-443(2008). RN [11] RP INTERACTION WITH SESTD1. RX PubMed=20164195; DOI=10.1074/jbc.M109.068304; RA Miehe S., Bieberstein A., Arnould I., Ihdene O., Rutten H., RA Strubing C.; RT "The phospholipid-binding protein SESTD1 is a novel regulator of the RT transient receptor potential channels TRPC4 and TRPC5."; RL J. Biol. Chem. 285:12426-12434(2010). RN [12] RP VARIANT THR-667. RX PubMed=23033978; DOI=10.1056/NEJMoa1206524; RA de Ligt J., Willemsen M.H., van Bon B.W., Kleefstra T., Yntema H.G., RA Kroes T., Vulto-van Silfhout A.T., Koolen D.A., de Vries P., RA Gilissen C., del Rosario M., Hoischen A., Scheffer H., de Vries B.B., RA Brunner H.G., Veltman J.A., Vissers L.E.; RT "Diagnostic exome sequencing in persons with severe intellectual RT disability."; RL N. Engl. J. Med. 367:1921-1929(2012). CC -!- FUNCTION: Thought to form a receptor-activated non-selective CC calcium permeant cation channel. Probably is operated by a CC phosphatidylinositol second messenger system activated by receptor CC tyrosine kinases or G-protein coupled receptors. Has also been CC shown to be calcium-selective (By similarity). May also be CC activated by intracellular calcium store depletion. {ECO:0000250, CC ECO:0000269|PubMed:16284075}. CC -!- ENZYME REGULATION: Calcium channel activity is enhanced by MYLK, CC that promotes its subcellular localization at the plasma membrane. CC {ECO:0000269|PubMed:16284075}. CC -!- SUBUNIT: Interacts with TRPC4AP (By similarity). Homotetramer and CC heterotetramer with TRPC1 and/or TRPC4. Interacts with NHERF (By CC similarity). Interacts with MX1 and RNF24. Interacts (via C- CC terminus) with CABP1. Interacts with SESTD1 (via the spectrin 1 CC repeat). {ECO:0000250, ECO:0000269|PubMed:12032305, CC ECO:0000269|PubMed:15757897, ECO:0000269|PubMed:15895247, CC ECO:0000269|PubMed:17850865, ECO:0000269|PubMed:20164195}. CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:16284075}; CC Multi-pass membrane protein {ECO:0000269|PubMed:16284075}. CC -!- TISSUE SPECIFICITY: Expressed in brain with higher levels in fetal CC brain. Found in cerebellum and occipital pole. CC {ECO:0000269|PubMed:9687496}. CC -!- SIMILARITY: Belongs to the transient receptor (TC 1.A.4) family. CC STrpC subfamily. TRPC5 sub-subfamily. {ECO:0000305}. CC -!- SIMILARITY: Contains 4 ANK repeats. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF054568; AAF00002.1; -; mRNA. DR EMBL; AC005191; AAC24563.1; -; Genomic_DNA. DR EMBL; AL049563; CAI43017.1; -; Genomic_DNA. DR EMBL; AC005191; CAI43017.1; JOINED; Genomic_DNA. DR EMBL; CH471120; EAX02630.1; -; Genomic_DNA. DR EMBL; BC137271; AAI37272.1; -; mRNA. DR EMBL; BC137274; AAI37275.1; -; mRNA. DR CCDS; CCDS14561.1; -. DR RefSeq; NP_036603.1; NM_012471.2. DR UniGene; Hs.657709; -. DR ProteinModelPortal; Q9UL62; -. DR SMR; Q9UL62; 45-180. DR BioGrid; 113075; 18. DR IntAct; Q9UL62; 1. DR STRING; 9606.ENSP00000262839; -. DR ChEMBL; CHEMBL1250411; -. DR GuidetoPHARMACOLOGY; 490; -. DR TCDB; 1.A.4.1.7; the transient receptor potential ca(2+) channel (trp-cc) family. DR iPTMnet; Q9UL62; -. DR PhosphoSite; Q9UL62; -. DR BioMuta; TRPC5; -. DR DMDM; 10720321; -. DR EPD; Q9UL62; -. DR MaxQB; Q9UL62; -. DR PaxDb; Q9UL62; -. DR PRIDE; Q9UL62; -. DR Ensembl; ENST00000262839; ENSP00000262839; ENSG00000072315. DR GeneID; 7224; -. DR KEGG; hsa:7224; -. DR UCSC; uc004epl.2; human. DR CTD; 7224; -. DR GeneCards; TRPC5; -. DR HGNC; HGNC:12337; TRPC5. DR HPA; HPA000510; -. DR MIM; 300334; gene. DR neXtProt; NX_Q9UL62; -. DR PharmGKB; PA37010; -. DR eggNOG; KOG3609; Eukaryota. DR eggNOG; ENOG410XQ0Y; LUCA. DR GeneTree; ENSGT00760000119180; -. DR HOGENOM; HOG000020589; -. DR HOVERGEN; HBG068337; -. DR InParanoid; Q9UL62; -. DR KO; K04968; -. DR OMA; NCSKSEI; -. DR OrthoDB; EOG72G17P; -. DR PhylomeDB; Q9UL62; -. DR TreeFam; TF313147; -. DR Reactome; R-HSA-3295583; TRP channels. DR Reactome; R-HSA-418890; Role of second messengers in netrin-1 signaling. DR ChiTaRS; TRPC5; human. DR GeneWiki; TRPC5; -. DR GenomeRNAi; 7224; -. DR NextBio; 28291; -. DR PRO; PR:Q9UL62; -. DR Proteomes; UP000005640; Chromosome X. DR Bgee; Q9UL62; -. DR CleanEx; HS_TRPC5; -. DR Genevisible; Q9UL62; HS. DR GO; GO:0034704; C:calcium channel complex; IDA:UniProtKB. DR GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc. DR GO; GO:0005886; C:plasma membrane; TAS:Reactome. DR GO; GO:0005262; F:calcium channel activity; IDA:UniProtKB. DR GO; GO:0070679; F:inositol 1,4,5 trisphosphate binding; IEA:Ensembl. DR GO; GO:0015279; F:store-operated calcium channel activity; TAS:ProtInc. DR GO; GO:0007411; P:axon guidance; TAS:Reactome. DR GO; GO:0070588; P:calcium ion transmembrane transport; TAS:Reactome. DR GO; GO:0006816; P:calcium ion transport; TAS:ProtInc. DR GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome. DR GO; GO:0006828; P:manganese ion transport; IBA:GO_Central. DR GO; GO:0007399; P:nervous system development; TAS:ProtInc. DR GO; GO:0051480; P:regulation of cytosolic calcium ion concentration; IBA:GO_Central. DR GO; GO:0055085; P:transmembrane transport; TAS:Reactome. DR Gene3D; 1.25.40.20; -; 1. DR InterPro; IPR002110; Ankyrin_rpt. DR InterPro; IPR020683; Ankyrin_rpt-contain_dom. DR InterPro; IPR005821; Ion_trans_dom. DR InterPro; IPR004729; TRP_channel. DR InterPro; IPR013555; TRP_dom. DR InterPro; IPR005461; TRPC5_channel. DR InterPro; IPR002153; TRPC_channel. DR PANTHER; PTHR10117; PTHR10117; 1. DR PANTHER; PTHR10117:SF24; PTHR10117:SF24; 1. DR Pfam; PF12796; Ank_2; 1. DR Pfam; PF00520; Ion_trans; 1. DR Pfam; PF08344; TRP_2; 1. DR PRINTS; PR01097; TRNSRECEPTRP. DR PRINTS; PR01646; TRPCHANNEL5. DR SMART; SM00248; ANK; 2. DR SUPFAM; SSF48403; SSF48403; 1. DR TIGRFAMs; TIGR00870; trp; 1. PE 1: Evidence at protein level; KW ANK repeat; Calcium; Calcium channel; Calcium transport; KW Cell membrane; Complete proteome; Glycoprotein; Ion channel; KW Ion transport; Membrane; Polymorphism; Reference proteome; Repeat; KW Transmembrane; Transmembrane helix; Transport. FT CHAIN 1 973 Short transient receptor potential FT channel 5. FT /FTId=PRO_0000215318. FT TOPO_DOM 1 330 Cytoplasmic. {ECO:0000255}. FT TRANSMEM 331 351 Helical. {ECO:0000255}. FT TOPO_DOM 352 398 Extracellular. {ECO:0000255}. FT TRANSMEM 399 419 Helical. {ECO:0000255}. FT TOPO_DOM 420 437 Cytoplasmic. {ECO:0000255}. FT TRANSMEM 438 458 Helical. {ECO:0000255}. FT TOPO_DOM 459 470 Extracellular. {ECO:0000255}. FT TRANSMEM 471 491 Helical. {ECO:0000255}. FT TOPO_DOM 492 512 Cytoplasmic. {ECO:0000255}. FT TRANSMEM 513 533 Helical. {ECO:0000255}. FT TOPO_DOM 534 603 Extracellular. {ECO:0000255}. FT TRANSMEM 604 624 Helical. {ECO:0000255}. FT TOPO_DOM 625 973 Cytoplasmic. {ECO:0000255}. FT REPEAT 31 60 ANK 1. FT REPEAT 69 97 ANK 2. FT REPEAT 98 124 ANK 3. FT REPEAT 141 170 ANK 4. FT REGION 971 973 Essential for binding to NHERF PDZ FT domain. {ECO:0000250}. FT CARBOHYD 461 461 N-linked (GlcNAc...). {ECO:0000255}. FT VARIANT 667 667 P -> T (found in a patient with severe FT delayed speech, autism spectrum and FT Gilles de la Tourette disorders). FT {ECO:0000269|PubMed:23033978}. FT /FTId=VAR_069415. FT VARIANT 702 702 R -> H (in dbSNP:rs36047478). FT /FTId=VAR_052369. SQ SEQUENCE 973 AA; 111412 MW; FBC8CBF17BE42166 CRC64; MAQLYYKKVN YSPYRDRIPL QIVRAETELS AEEKAFLNAV EKGDYATVKQ ALQEAEIYYN VNINCMDPLG RSALLIAIEN ENLEIMELLL NHSVYVGDAL LYAIRKEVVG AVELLLSYRR PSGEKQVPTL MMDTQFSEFT PDITPIMLAA HTNNYEIIKL LVQKRVTIPR PHQIRCNCVE CVSSSEVDSL RHSRSRLNIY KALASPSLIA LSSEDPILTA FRLGWELKEL SKVENEFKAE YEELSQQCKL FAKDLLDQAR SSRELEIILN HRDDHSEELD PQKYHDLAKL KVAIKYHQKE FVAQPNCQQL LATLWYDGFP GWRRKHWVVK LLTCMTIGFL FPMLSIAYLI SPRSNLGLFI KKPFIKFICH TASYLTFLFM LLLASQHIVR TDLHVQGPPP TVVEWMILPW VLGFIWGEIK EMWDGGFTEY IHDWWNLMDF AMNSLYLATI SLKIVAYVKY NGSRPREEWE MWHPTLIAEA LFAISNILSS LRLISLFTAN SHLGPLQISL GRMLLDILKF LFIYCLVLLA FANGLNQLYF YYETRAIDEP NNCKGIRCEK QNNAFSTLFE TLQSLFWSVF GLLNLYVTNV KARHEFTEFV GATMFGTYNV ISLVVLLNML IAMMNNSYQL IADHADIEWK FARTKLWMSY FDEGGTLPPP FNIIPSPKSF LYLGNWFNNT FCPKRDPDGR RRRRNLRSFT ERNADSLIQN QHYQEVIRNL VKRYVAAMIR NSKTHEGLTE ENFKELKQDI SSFRYEVLDL LGNRKHPRSF STSSTELSQR DDNNDGSGGA RAKSKSVSFN LGCKKKTCHG PPLIRTMPRS SGAQGKSKAE SSSKRSFMGP SLKKLGLLFS KFNGHMSEPS SEPMYTISDG IVQQHCMWQD IRYSQMEKGK AEACSQSEIN LSEVELGEVQ GAAQSSECPL ACSSSLHCAS SICSSNSKLL DSSEDVFETW GEACDLLMHK WGDGQEEQVT TRL //